The first Cleveland BioLabs trade was made in Q3 2016.
Since then Ken Griffin bought shares six more times and sold shares on seven occasions. The investor sold all their shares in Q2 2021 and doesn't own any shares in Cleveland BioLabs anymore.
Avg closing price
Price range
Sold -36.6 Thousand shares
Q2 2021
Avg closing price
$5.38
Price range
$4.49
-
$6.95
New holding (+36.6 Thousand shares)
Q1 2021
Avg closing price
$5.47
Price range
$3.50
-
$9.55
Sold -12 Thousand shares
Q2 2020
Avg closing price
$1.81
Price range
$1.45
-
$4.26
New holding (+12 Thousand shares)
Q1 2020
Avg closing price
$2.04
Price range
$0.57
-
$4.23
Sold -28.4 Thousand shares
Q4 2019
Avg closing price
$0.74
Price range
$0.51
-
$1.02
New holding (+28.4 Thousand shares)
Q3 2019
Avg closing price
$1.35
Price range
$1.01
-
$1.57
Sold -15.4 Thousand shares
Q3 2018
Avg closing price
$2.15
Price range
$1.77
-
$2.58
Increased shares by 14.0% (+1.89 Thousand shares)
Q2 2018